Filing Details
- Accession Number:
- 0001519749-22-000004
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-03-01 16:55:02
- Reporting Period:
- 2022-02-28
- Accepted Time:
- 2022-03-01 16:55:02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 899923 | Myriad Genetics Inc | MYGN | In Vitro & In Vivo Diagnostic Substances (2835) | 870494517 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1519749 | B. Jayne Hart | 320 Wakara Way Salt Lake City UT 84108 | Chief People Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-02-28 | 7,000 | $23.98 | 172,878 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-02-28 | 7,000 | $25.00 | 165,878 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-02-28 | 3,500 | $23.98 | 169,378 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-02-28 | 3,500 | $25.00 | 165,878 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2022-02-28 | 3,500 | $0.00 | 3,500 | $23.98 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2022-02-28 | 7,000 | $0.00 | 7,000 | $23.98 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2022-03-07 | No | 4 | M | Direct | |
| 0 | 2022-03-07 | No | 4 | M | Direct |
Footnotes
- The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
- Represents shares of common stock received upon exercise of a stock option award.
- The shares subject to this option are fully vested and exercisable.
Billionaire Hedge Funds
